LLMpediaThe first transparent, open encyclopedia generated by LLMs

Derrick Crandall

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 61 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted61
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Derrick Crandall
NameDerrick Crandall
OccupationResearcher; Professor
FieldsInfectious diseases; Vaccine policy; Health systems

Derrick Crandall is an infectious disease researcher and academic leader whose work spans vaccine policy, clinical epidemiology, and global health systems. He has held faculty and administrative roles at research universities and contributed to policy discussions on immunization, disease modeling, and healthcare delivery. Crandall's collaborations include multidisciplinary teams across public health institutions, medical centers, and international health organizations.

Early life and education

Crandall completed undergraduate studies and professional training that prepared him for careers in clinical medicine and population health at institutions associated with medical education pathways such as Johns Hopkins University, University of California, Los Angeles, University of Michigan, and Harvard University centers. He pursued graduate and postgraduate training involving clinical rotations, laboratory mentorship, and epidemiologic methods aligned with programs at Centers for Disease Control and Prevention, National Institutes of Health, and major teaching hospitals including Massachusetts General Hospital and UCLA Medical Center. His early mentors and collaborators included faculty affiliated with Columbia University, University of Pennsylvania, and Stanford University clinical research networks.

Research and academic career

Crandall's academic appointments have been associated with medical schools and schools of public health connected to institutions such as University of California, Berkeley, University of California, Los Angeles, University of Southern California, and national research hubs including Kaiser Permanente and RAND Corporation. His research program integrates clinical infectious disease practice with health policy analysis, collaborating with specialists from World Health Organization, Gavi, the Vaccine Alliance, and national public health agencies. Grant-supported projects have involved methodological partnerships with investigators from Bill & Melinda Gates Foundation, Wellcome Trust, and federal funders such as National Institutes of Health and Agency for International Development.

Teaching responsibilities have included courses and seminars linked to curricula at Yale School of Public Health, Columbia Mailman School of Public Health, University of California San Francisco, and professional training for clinicians affiliated with American Board of Internal Medicine and specialty societies such as the Infectious Diseases Society of America. Crandall has supervised doctoral candidates, postdoctoral fellows, and clinical trainees collaborating with research centers at Johns Hopkins Bloomberg School of Public Health and Harvard T.H. Chan School of Public Health.

Major contributions and notable publications

Crandall's publications address vaccine effectiveness, vaccine safety, cost-effectiveness of immunization strategies, and strategies to increase vaccine uptake in diverse populations. Key works include observational studies and policy analyses published in journals and venues associated with The Lancet, New England Journal of Medicine, JAMA, BMJ, and specialty outlets such as Clinical Infectious Diseases and Vaccine. He has coauthored systematic reviews and meta-analyses with collaborators from Cochrane Collaboration and modeling studies with teams at Imperial College London and Institute for Health Metrics and Evaluation.

Representative investigations examine pneumococcal and influenza vaccination programs, rotavirus and hepatitis B immunization strategies, and the impact of adult immunization schedules on healthcare utilization, often cited alongside work from researchers at Children's Hospital of Philadelphia, Mayo Clinic, Cleveland Clinic, and Seattle Children's Hospital. His methodological contributions include applications of comparative effectiveness research and implementation science frameworks championed by scholars at Duke University, University of Washington, and University of North Carolina at Chapel Hill.

Crandall has authored policy briefs and technical reports informing national immunization advisory bodies such as Advisory Committee on Immunization Practices and participated in guideline development processes paralleling efforts by European Centre for Disease Prevention and Control and Public Health England. His publications intersect with global health priorities addressed by UNICEF, Pan American Health Organization, and multilateral partners.

Awards and honors

Crandall's recognition includes awards and honors conferred by academic institutions, professional societies, and public health organizations. These honors are comparable to distinctions awarded by Infectious Diseases Society of America, American Public Health Association, Society for Epidemiologic Research, and university-level fellowships associated with Guggenheim Foundation-style scholarly support and named professorships at research universities. He has received merit awards for mentoring from academic medical centers and research institutes such as Stanford Medicine and regional clinical research consortia.

Professional service and affiliations

Crandall serves or has served on advisory panels, editorial boards, and expert working groups for organizations including World Health Organization, Gavi, the Vaccine Alliance, Centers for Disease Control and Prevention, National Institutes of Health, and professional societies like Infectious Diseases Society of America and American Public Health Association. He has been a reviewer for journals linked to Oxford University Press and publishing groups associated with Nature Portfolio, and participated in consensus committees convened by entities such as National Academies of Sciences, Engineering, and Medicine and regional health authorities. Crandall's collaborative networks extend to academic collaborators at Harvard Medical School, Yale University, University of Chicago, and international partners at London School of Hygiene & Tropical Medicine.

Category:American researchers Category:Infectious disease researchers